Calprotectin Testing Market by Test Kits, Sample, Indication, End User & Region | Forecast 2023 to 2033
Health Providers Increase the Demand for Calprotectin Testing Devices to Detect Patients Early Inflammation and Improve through Non-invasive Methods. FMI Analysis Opportunities with Japan, Germany, the United States, and 20+ More Countries
Calprotectin Testing Market Outlook (2023 to 2033)
The calprotectin testing market is capturing a valuation of US$ 201.1 billion in 2023 and is predicted to reach US$ 360.2 billion by 2033. The market is registering a CAGR of 6% during the forecast period.
The market is driven by various factors, including:
Prevalence of Inflammatory Bowel Disease: Rising inflammatory bowel disease among patients.
Rising Demand for Non-invasive Diagnostic Tools: Patients are increasing the demand for calprotectin testing to detect chronic disease and enhance the procedure of non-invasive diagnostics.
Advanced Technology: The growing technology to improve the reliability and accuracy of calprotectin testing. For instance, new testing devices are developed to detect the patient's disease and provide rapid results.
Growing Awareness: Healthcare providers growing awareness among consumers about the benefits of testing equipment is advancing the market opportunities.
Rising Healthcare Sector: The healthcare sector is rapidly growing due to the development of effective and efficient healthcare services. This calprotectin testing help reduces costs, manage chronic disease effectively, and detect early symptoms.
Lack of Awareness and Low Standardized Product Limit the Market Growth
Various factors restrain market growth are:
Lack of Standardization: The low-quality calprotectin testing, limited features, and cut-off values. This equipment affects the reliability and accuracy of detecting patients' chronic conditions.
High Cost: The manufacturers develop expensive non-invasive diagnostic tools compared to other testing tools. It may limit the adoption of calprotectin testing devices in several healthcare sectors. The developing countries decline to adopt these testing due to their budget limits.
Alternative Diagnostic Tools: Healthcare providers choose other diagnostic tools due to their unavailability and high costs.
Limited Awareness: Patients are unaware of calprotectin testing and its benefits. Several healthcare providers are still not adopting this tool due to unavailability, which may also affect the demand.
Attributes
Details
Market CAGR (2023 to 2033)
6%
Market Valuation (2023)
US$ 201.1 billion
Market Valuation (2033)
US$ 360.2 billion
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Calprotectin Testing Market, 2018 to 2022 Historical Sales, Compared to 2023 to 2033 Future Outlook
The market experienced steady growth between 2018 and 2022. The market was valued at US$ 190.5 billion in 2022, with a CAGR of 5.3% between 2018 and 2022. A surge in chronic patients, increasing demand for non-invasive diagnostic tools, and growing advanced technology have driven the market size.
The market has faced various challenges, such as limited awareness, low-quality tools, and high competition. The various end-use sectors, such as hospitals, specialty clinics, and others, continuously grow the market revenue during the forecast period. Healthcare manufacturers are developing advanced tools to detect and monitor patients' chronic conditions.
Short Term (2023 to 2026): Increasing old age population, rising demand for reliable diagnostic tools, and growing chronic diseases drive the global market size. Developed countries are experimenting with providing accurate and effective tools that help to detect patients' conditions quickly.
Medium Term (2026 to 2029): The rising advanced technologies, innovation of testing equipment for better healthcare services, and growing awareness drive the market growth. The innovation of advanced non-invasive diagnostic tools is expected to fuel the market size in this time frame.
Long Term (2029 to 2033): The increasing research and development activities and government support to expand the healthcare sector propel market opportunities. Diagnostic laboratories are key to developing advanced testing equipment to treat patients.
Comparative Analysis of Adjacent Markets
Calprotectin Testing Market:
Attributes
Calprotectin Testing Market
CAGR (2023 to 2033)
6%
Value (2023)
US$ 201.1 billion
Value (2033)
US$ 360.2 billion
Trends
Rising old age population, growing chronic diseases, and increasing demand for high-quality testing devices
Opportunities
The growing healthcare sector, increasing research and development activities. Moreover, the innovation of advanced testing diagnostic devices and government supports
Self-testing Market:
Attributes
Self-testing Market
CAGR (2023 to 2033)
5.6%
Value (2023)
US$ 7.89 billion
Value (2033)
US$ 13.6 billion
Trends
Growing technology, innovation of user-friendly testing devices, and smart self-testing devices
Opportunities
Growing new technologies, innovation, research, and development activities
Medical Device Testing Market:
Attributes
Medical Device Testing Market
CAGR (2023 to 2033)
4.8%
Value (2023)
US$ 10.74 billion
Value (2033)
US$ 17.16 billion
Trends
Growing chronic diseases, rising patients awareness, adoption of advanced technologies such as Artificial Intelligence
Opportunities
Rising huge investments by the government and key players in the healthcare industry
Find your sweet spots for generating winning opportunities in this market.
The Top Categories Advancing the Global Market are
Calprotectin ELISA Test Kits are Highly Sought-after in the Global Market
Based on test kits, calprotectin ELISA test kits are estimated to dominate the global market by securing a share of 90.46% during the forecast period. The laboratory's adoption of calprotectin ELISA test kits is increasing to detect and qualify biological samples. These kits help measure the calprotectin level, advancing the market growth.
The demand for calprotectin ELISA test kits is rising due to their ability to collect multiple samples and ease to use with high sensitivity. The growing popularity of these devices among healthcare professionals is fueling the market size. The manufacturers are distributors offering multiple kits with their respective uses, and benefits are advancing the market opportunities.
Which Indication Category Leads the Global Market?
Based on indication, irritable bowel syndrome is anticipated to lead the global market by registering a share of 79% during the forecast period. Irritable bowel syndrome is a prime indication segment that affects the large intestine. The rising prevalence of irritable bowel syndrome surges the demand for calprotectin testing.
The Top Countries that Influenced the Global Market are
Countries
Projected Value (2023 to 2033)
United States
25.7%
Germany
3%
Japan
3.1%
Australia
5.6%
China
7.8%
India
8.7%
United Kingdom
6.2%
Growing Advanced Testing Technology Upsurge the United States Market
The United States is estimated to dominate the global market by securing a share of 25.7% during the forecast period. The increasingly advanced testing technology and growing patient awareness fuel the country's market size. The growth in gastrointestinal disorders and chronic diseases is increasing the adoption of calprotectin testing in the healthcare sector.
Healthcare manufacturers are developing advanced testing equipment to monitor patients' diseases and enhance the performance of checkups. These manufacturers offer a variety of testing tools to monitor the diagnostic condition of patients. Additionally, provide better services expanding the United States calprotectin testing market.
How Does Germany Drive the Global Market Revenue?
Germany is one of the significant countries in the global market that secure a share of 3% during the forecast period. Various factors are driving the German market are:
Growing Healthcare Infrastructure: Germany is known for its strong healthcare infrastructure. The healthcare providers focus on developing calprotectin testing devices to detect and prevent early symptoms.
Rising Inflammatory Bowel Disease: The increasing incidence of inflammatory bowel disease is growing in Germany's market size. The country is rapidly growing in chronic diseases with the huge inflammatory bowel disease rates.
Increasing Awareness: Germany continuously grows awareness about calprotectin testing and its essential uses and quick monitoring system. Physicians prefer to increase the adoption of these testing tools for their patients.
Growing Research and Development: The leading manufacturers in Germany, such as Calpro AS and others, are contributing a vital role in the market. The key companies invest in research and development activities to improve reliability and accuracy.
Growing Aging Population Upsurge Japan Market
Japan is one of the significant countries in the global market, capturing a share of 3.1% during the forecast period. The rising prevalence of inflammatory bowel disease is fueling the market growth in Japan. For Instance, around 2,00,000 people have been affected by inflammatory bowel disease recently.
The aging population and chronic patients are increasing the demand for calprotectin testing in Japan. The surging demand for diagnostic tests among patients is increasing the adoption of these testing tools. The manufacturers in Japan are investing in research and development activities to upsurge the medical field. Several Japanese companies are improving testing devices to provide accuracy in testing.
The increasing aging population and strong research activities are innovating unique products that satisfy healthcare providers' and patients' requirements. These factors are contributing to uplifting Japan's calprotectin testing market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
How can Manufacturers Expand the Global Market?
With the following steps, the manufacturers can expand the global market are:
Developing Innovative Products: Manufacturers can expand the market through their innovation to offer better, cost-effective, and more reliable testing devices. They provide easy-to-use and accurate result tools to enhance the patient testing experience.
Provide Competitive Prices: The manufacturers develop calprotectin testing products at competitive prices by reducing costs and increasing production. These testing tools are more efficient as compared to other diagnostic testing tools. Therefore, manufacturers are increasing their production processes to expand the market revenue.
Distribution Networks: Manufacturers increase their distribution networks to enhance their reach to attract more consumers. They are partnering with distributors and promote their products by advertising and marketing to reach relevant customers. Through these, the manufacturers build trust and transparency in their products.
Training and Supports: Manufacturers train healthcare providers on their newly launched products. It helps them use it efficiently, building trust and loyalty to their brand.
Conduct Clinical Trials: Clinical trial is an effective solution to check the effectiveness of the testing tool. It helps them to build credibility among patients and healthcare providers.
These are a few steps on which the manufacturers can expand the global market.
Competitive Landscape
Several key players highly influence the market. The key players are developing unique and advanced testing devices to detect and monitor patients' chronic diseases. They are investing in research and development activities and offer better solutions with advanced technologies.
These players are fueling the healthcare sector by increasing their services as per consumers' needs. The players are adopting various marketing tactics to enhance the global market size. These marketing strategies are collaborations, acquisitions, mergers, partnerships, agreements, and product launches.
Other Essential Players in the Market are:
Actim Oy
Calpro AS
BÜHLMANN Laboratories AG
EagleBio
CerTest Biotec S.L.
EUROIMMUN Medizinische Labordiagnostika AG
Boditech Med Inc.
Biohit Oyj
American Laboratory Products Company, Ltd.
DIAsource ImmunoAssays S.A
R-Biopharm AG.
Abbexa
AccuBio Tech Co., Ltd.
Screen Italia Srl.
Hangzhou Biotest Biotech Co., Ltd
Thermo Fisher Scientific
Epitope Diagnostics, Inc.
Elabscience Biotechnology Inc
Vitassay Healthcare, S.L.U.
Beckman Coulter Inc.
DiaSorin
Recent Development in the Global Market are:
In 2021, BÜHLMANN Laboratories AG announced its newly launched calprotectin point-of-care test, Quantum Blue fCAL turbo.
In 2020, Biohit Healthcare launched its calprotectin ELISA kit test for laboratory sample purposes to measure the level of calprotectin.
In 2021, Calpro AS announced its newly launched test CalproSmart. It provides a digital and fully automated test to monitor patients' diagnosis and monitor inflammatory bowel disease.
In 2021, Alpha Laboratories Ltd launched the fCAL turbo assay that quickly and accurately measures calprotectin levels.
Scope of Report
Attribute
Details
Forecast Period
2023 to 2033
Historical Data Available for
2018 to 2022
Market Analysis
US$ billion for Value
Key Countries Covered
The United States, The United Kingdom, Japan, India, China, Australia, Germany
Key Segments Covered
Test Kit
Sample
Indication
End Use
Region
Key Companies Profiled
Actim Oy
Calpro AS
BÜHLMANN Laboratories AG
EagleBio
CerTest Biotec S.L.
EUROIMMUN Medizinische Labordiagnostika AG
Boditech Med Inc.
Biohit Oyj
American Laboratory Products Company, Ltd.
DIAsource ImmunoAssays S.A
R-Biopharm AG.
Abbexa
AccuBio Tech Co., Ltd.
Screen Italia Srl.
Hangzhou Biotest Biotech Co., Ltd
Thermo Fisher Scientific
Epitope Diagnostics, Inc.
Elabscience Biotechnology Inc
Vitassay Healthcare, S.L.U.
Beckman Coulter Inc.
DiaSorin
Report Coverage
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
1. Executive Summary | Calprotectin Testing Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Kits
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Test Kits, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Kits, 2023 to 2033
5.3.1. Calprotectin ELISA
5.3.2. Calprotectin Rapid
5.4. Y-o-Y Growth Trend Analysis By Test Kits, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Test Kits, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sample
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Sample, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sample, 2023 to 2033
6.3.1. Stool
6.3.2. Plasma
6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By Sample, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Sample, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Indication , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication , 2023 to 2033
7.3.1. Irritable Bowel Syndrome (IBS)
7.3.2. Ulcerative Colitis
7.3.3. Crohn's Disease
7.3.4. Colorectal Cancer
7.4. Y-o-Y Growth Trend Analysis By Indication , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Indication , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2023 to 2033
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Specialty Clinics
8.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. United States of America
10.2.1.2. Canada
10.2.2. By Test Kits
10.2.3. By Sample
10.2.4. By Indication
10.2.5. By End-User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Kits
10.3.3. By Sample
10.3.4. By Indication
10.3.5. By End-User
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Test Kits
11.2.3. By Sample
11.2.4. By Indication
11.2.5. By End-User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test Kits
11.3.3. By Sample
11.3.4. By Indication
11.3.5. By End-User
11.4. Key Takeaways
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. United Kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Test Kits
12.2.3. By Sample
12.2.4. By Indication
12.2.5. By End-User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Test Kits
12.3.3. By Sample
12.3.4. By Indication
12.3.5. By End-User
12.4. Key Takeaways
13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Malaysia
13.2.1.3. Singapore
13.2.1.4. Thailand
13.2.1.5. Rest of South Asia
13.2.2. By Test Kits
13.2.3. By Sample
13.2.4. By Indication
13.2.5. By End-User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Test Kits
13.3.3. By Sample
13.3.4. By Indication
13.3.5. By End-User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Test Kits
14.2.3. By Sample
14.2.4. By Indication
14.2.5. By End-User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Test Kits
14.3.3. By Sample
14.3.4. By Indication
14.3.5. By End-User
14.4. Key Takeaways
15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Test Kits
15.2.3. By Sample
15.2.4. By Indication
15.2.5. By End-User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Test Kits
15.3.3. By Sample
15.3.4. By Indication
15.3.5. By End-User
15.4. Key Takeaways
16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Test Kits
16.2.3. By Sample
16.2.4. By Indication
16.2.5. By End-User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Test Kits
16.3.3. By Sample
16.3.4. By Indication
16.3.5. By End-User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. United States of America
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Test Kits
17.1.2.2. By Sample
17.1.2.3. By Indication
17.1.2.4. By End-User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Test Kits
17.2.2.2. By Sample
17.2.2.3. By Indication
17.2.2.4. By End-User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Test Kits
17.3.2.2. By Sample
17.3.2.3. By Indication
17.3.2.4. By End-User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Test Kits
17.4.2.2. By Sample
17.4.2.3. By Indication
17.4.2.4. By End-User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Test Kits
17.5.2.2. By Sample
17.5.2.3. By Indication
17.5.2.4. By End-User
17.6. United Kingdom
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Test Kits
17.6.2.2. By Sample
17.6.2.3. By Indication
17.6.2.4. By End-User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Test Kits
17.7.2.2. By Sample
17.7.2.3. By Indication
17.7.2.4. By End-User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Test Kits
17.8.2.2. By Sample
17.8.2.3. By Indication
17.8.2.4. By End-User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Test Kits
17.9.2.2. By Sample
17.9.2.3. By Indication
17.9.2.4. By End-User
17.10. India
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Test Kits
17.10.2.2. By Sample
17.10.2.3. By Indication
17.10.2.4. By End-User
17.11. Malaysia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Test Kits
17.11.2.2. By Sample
17.11.2.3. By Indication
17.11.2.4. By End-User
17.12. Singapore
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Test Kits
17.12.2.2. By Sample
17.12.2.3. By Indication
17.12.2.4. By End-User
17.13. Thailand
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Test Kits
17.13.2.2. By Sample
17.13.2.3. By Indication
17.13.2.4. By End-User
17.14. China
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Test Kits
17.14.2.2. By Sample
17.14.2.3. By Indication
17.14.2.4. By End-User
17.15. Japan
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Test Kits
17.15.2.2. By Sample
17.15.2.3. By Indication
17.15.2.4. By End-User
17.16. South Korea
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Test Kits
17.16.2.2. By Sample
17.16.2.3. By Indication
17.16.2.4. By End-User
17.17. Australia
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Test Kits
17.17.2.2. By Sample
17.17.2.3. By Indication
17.17.2.4. By End-User
17.18. New Zealand
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Test Kits
17.18.2.2. By Sample
17.18.2.3. By Indication
17.18.2.4. By End-User
17.19. GCC Countries
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Test Kits
17.19.2.2. By Sample
17.19.2.3. By Indication
17.19.2.4. By End-User
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Test Kits
17.20.2.2. By Sample
17.20.2.3. By Indication
17.20.2.4. By End-User
17.21. Israel
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Test Kits
17.21.2.2. By Sample
17.21.2.3. By Indication
17.21.2.4. By End-User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Test Kits
18.3.3. By Sample
18.3.4. By Indication
18.3.5. By End-User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Actim Oy
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Calpro AS
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. BÜHLMANN Laboratories AG
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. EagleBio
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. CerTest Biotec S.L.
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. EUROIMMUN Medizinische Labordiagnostika AG
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Boditech Med Inc.
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Biohit Oyj
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. American Laboratory Products Company, Ltd.
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. DIAsource ImmunoAssays S.A
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.11. R-Biopharm AG.
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.12. Abbexa
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.13. AccuBio Tech Co., Ltd.
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
19.1.14. Screen Italia Srl.
19.1.14.1. Overview
19.1.14.2. Product Portfolio
19.1.14.3. Profitability by Market Segments
19.1.14.4. Sales Footprint
19.1.14.5. Strategy Overview
19.1.14.5.1. Marketing Strategy
19.1.15. Hangzhou Biotest Biotech Co., Ltd
19.1.15.1. Overview
19.1.15.2. Product Portfolio
19.1.15.3. Profitability by Market Segments
19.1.15.4. Sales Footprint
19.1.15.5. Strategy Overview
19.1.15.5.1. Marketing Strategy
20. Assumptions & Acronyms Used21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Test Kits, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Sample, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 5: Global Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Test Kits, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by Sample, 2018 to 2033
Table 9: North America Market Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 10: North America Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by Test Kits, 2018 to 2033
Table 13: Latin America Market Value (US$ Million) Forecast by Sample, 2018 to 2033
Table 14: Latin America Market Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 15: Latin America Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 16: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: Europe Market Value (US$ Million) Forecast by Test Kits, 2018 to 2033
Table 18: Europe Market Value (US$ Million) Forecast by Sample, 2018 to 2033
Table 19: Europe Market Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 20: Europe Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 21: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: South Asia Market Value (US$ Million) Forecast by Test Kits, 2018 to 2033
Table 23: South Asia Market Value (US$ Million) Forecast by Sample, 2018 to 2033
Table 24: South Asia Market Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 25: South Asia Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 26: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 27: East Asia Market Value (US$ Million) Forecast by Test Kits, 2018 to 2033
Table 28: East Asia Market Value (US$ Million) Forecast by Sample, 2018 to 2033
Table 29: East Asia Market Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 30: East Asia Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 31: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 32: Oceania Market Value (US$ Million) Forecast by Test Kits, 2018 to 2033
Table 33: Oceania Market Value (US$ Million) Forecast by Sample, 2018 to 2033
Table 34: Oceania Market Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 35: Oceania Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 36: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 37: MEA Market Value (US$ Million) Forecast by Test Kits, 2018 to 2033
Table 38: MEA Market Value (US$ Million) Forecast by Sample, 2018 to 2033
Table 39: MEA Market Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 40: MEA Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Test Kits, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Sample, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Indication, 2023 to 2033
Figure 4: Global Market Value (US$ Million) by End-User, 2023 to 2033
Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 9: Global Market Value (US$ Million) Analysis by Test Kits, 2018 to 2033
Figure 10: Global Market Value Share (%) and BPS Analysis by Test Kits, 2023 to 2033
Figure 11: Global Market Y-o-Y Growth (%) Projections by Test Kits, 2023 to 2033
Figure 12: Global Market Value (US$ Million) Analysis by Sample, 2018 to 2033
Figure 13: Global Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033
Figure 14: Global Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033
Figure 15: Global Market Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 16: Global Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 17: Global Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 18: Global Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 19: Global Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 20: Global Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 21: Global Market Attractiveness by Test Kits, 2023 to 2033
Figure 22: Global Market Attractiveness by Sample, 2023 to 2033
Figure 23: Global Market Attractiveness by Indication, 2023 to 2033
Figure 24: Global Market Attractiveness by End-User, 2023 to 2033
Figure 25: Global Market Attractiveness by Region, 2023 to 2033
Figure 26: North America Market Value (US$ Million) by Test Kits, 2023 to 2033
Figure 27: North America Market Value (US$ Million) by Sample, 2023 to 2033
Figure 28: North America Market Value (US$ Million) by Indication, 2023 to 2033
Figure 29: North America Market Value (US$ Million) by End-User, 2023 to 2033
Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by Test Kits, 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Test Kits, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Test Kits, 2023 to 2033
Figure 37: North America Market Value (US$ Million) Analysis by Sample, 2018 to 2033
Figure 38: North America Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033
Figure 39: North America Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033
Figure 40: North America Market Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 41: North America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 42: North America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 43: North America Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 44: North America Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 45: North America Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 46: North America Market Attractiveness by Test Kits, 2023 to 2033
Figure 47: North America Market Attractiveness by Sample, 2023 to 2033
Figure 48: North America Market Attractiveness by Indication, 2023 to 2033
Figure 49: North America Market Attractiveness by End-User, 2023 to 2033
Figure 50: North America Market Attractiveness by Country, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) by Test Kits, 2023 to 2033
Figure 52: Latin America Market Value (US$ Million) by Sample, 2023 to 2033
Figure 53: Latin America Market Value (US$ Million) by Indication, 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) by End-User, 2023 to 2033
Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 59: Latin America Market Value (US$ Million) Analysis by Test Kits, 2018 to 2033
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Test Kits, 2023 to 2033
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Test Kits, 2023 to 2033
Figure 62: Latin America Market Value (US$ Million) Analysis by Sample, 2018 to 2033
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033
Figure 65: Latin America Market Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 68: Latin America Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 69: Latin America Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 71: Latin America Market Attractiveness by Test Kits, 2023 to 2033
Figure 72: Latin America Market Attractiveness by Sample, 2023 to 2033
Figure 73: Latin America Market Attractiveness by Indication, 2023 to 2033
Figure 74: Latin America Market Attractiveness by End-User, 2023 to 2033
Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 76: Europe Market Value (US$ Million) by Test Kits, 2023 to 2033
Figure 77: Europe Market Value (US$ Million) by Sample, 2023 to 2033
Figure 78: Europe Market Value (US$ Million) by Indication, 2023 to 2033
Figure 79: Europe Market Value (US$ Million) by End-User, 2023 to 2033
Figure 80: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 84: Europe Market Value (US$ Million) Analysis by Test Kits, 2018 to 2033
Figure 85: Europe Market Value Share (%) and BPS Analysis by Test Kits, 2023 to 2033
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Test Kits, 2023 to 2033
Figure 87: Europe Market Value (US$ Million) Analysis by Sample, 2018 to 2033
Figure 88: Europe Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033
Figure 90: Europe Market Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 91: Europe Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 93: Europe Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 94: Europe Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 95: Europe Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 96: Europe Market Attractiveness by Test Kits, 2023 to 2033
Figure 97: Europe Market Attractiveness by Sample, 2023 to 2033
Figure 98: Europe Market Attractiveness by Indication, 2023 to 2033
Figure 99: Europe Market Attractiveness by End-User, 2023 to 2033
Figure 100: Europe Market Attractiveness by Country, 2023 to 2033
Figure 101: South Asia Market Value (US$ Million) by Test Kits, 2023 to 2033
Figure 102: South Asia Market Value (US$ Million) by Sample, 2023 to 2033
Figure 103: South Asia Market Value (US$ Million) by Indication, 2023 to 2033
Figure 104: South Asia Market Value (US$ Million) by End-User, 2023 to 2033
Figure 105: South Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 106: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 107: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 108: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 109: South Asia Market Value (US$ Million) Analysis by Test Kits, 2018 to 2033
Figure 110: South Asia Market Value Share (%) and BPS Analysis by Test Kits, 2023 to 2033
Figure 111: South Asia Market Y-o-Y Growth (%) Projections by Test Kits, 2023 to 2033
Figure 112: South Asia Market Value (US$ Million) Analysis by Sample, 2018 to 2033
Figure 113: South Asia Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033
Figure 114: South Asia Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033
Figure 115: South Asia Market Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 116: South Asia Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 117: South Asia Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 118: South Asia Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 119: South Asia Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 120: South Asia Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 121: South Asia Market Attractiveness by Test Kits, 2023 to 2033
Figure 122: South Asia Market Attractiveness by Sample, 2023 to 2033
Figure 123: South Asia Market Attractiveness by Indication, 2023 to 2033
Figure 124: South Asia Market Attractiveness by End-User, 2023 to 2033
Figure 125: South Asia Market Attractiveness by Country, 2023 to 2033
Figure 126: East Asia Market Value (US$ Million) by Test Kits, 2023 to 2033
Figure 127: East Asia Market Value (US$ Million) by Sample, 2023 to 2033
Figure 128: East Asia Market Value (US$ Million) by Indication, 2023 to 2033
Figure 129: East Asia Market Value (US$ Million) by End-User, 2023 to 2033
Figure 130: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 131: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 134: East Asia Market Value (US$ Million) Analysis by Test Kits, 2018 to 2033
Figure 135: East Asia Market Value Share (%) and BPS Analysis by Test Kits, 2023 to 2033
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Test Kits, 2023 to 2033
Figure 137: East Asia Market Value (US$ Million) Analysis by Sample, 2018 to 2033
Figure 138: East Asia Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033
Figure 139: East Asia Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033
Figure 140: East Asia Market Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 141: East Asia Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 142: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 143: East Asia Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 144: East Asia Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 145: East Asia Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 146: East Asia Market Attractiveness by Test Kits, 2023 to 2033
Figure 147: East Asia Market Attractiveness by Sample, 2023 to 2033
Figure 148: East Asia Market Attractiveness by Indication, 2023 to 2033
Figure 149: East Asia Market Attractiveness by End-User, 2023 to 2033
Figure 150: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 151: Oceania Market Value (US$ Million) by Test Kits, 2023 to 2033
Figure 152: Oceania Market Value (US$ Million) by Sample, 2023 to 2033
Figure 153: Oceania Market Value (US$ Million) by Indication, 2023 to 2033
Figure 154: Oceania Market Value (US$ Million) by End-User, 2023 to 2033
Figure 155: Oceania Market Value (US$ Million) by Country, 2023 to 2033
Figure 156: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 157: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 158: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 159: Oceania Market Value (US$ Million) Analysis by Test Kits, 2018 to 2033
Figure 160: Oceania Market Value Share (%) and BPS Analysis by Test Kits, 2023 to 2033
Figure 161: Oceania Market Y-o-Y Growth (%) Projections by Test Kits, 2023 to 2033
Figure 162: Oceania Market Value (US$ Million) Analysis by Sample, 2018 to 2033
Figure 163: Oceania Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033
Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033
Figure 165: Oceania Market Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 166: Oceania Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 167: Oceania Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 168: Oceania Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 169: Oceania Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 170: Oceania Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 171: Oceania Market Attractiveness by Test Kits, 2023 to 2033
Figure 172: Oceania Market Attractiveness by Sample, 2023 to 2033
Figure 173: Oceania Market Attractiveness by Indication, 2023 to 2033
Figure 174: Oceania Market Attractiveness by End-User, 2023 to 2033
Figure 175: Oceania Market Attractiveness by Country, 2023 to 2033
Figure 176: MEA Market Value (US$ Million) by Test Kits, 2023 to 2033
Figure 177: MEA Market Value (US$ Million) by Sample, 2023 to 2033
Figure 178: MEA Market Value (US$ Million) by Indication, 2023 to 2033
Figure 179: MEA Market Value (US$ Million) by End-User, 2023 to 2033
Figure 180: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 181: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 184: MEA Market Value (US$ Million) Analysis by Test Kits, 2018 to 2033
Figure 185: MEA Market Value Share (%) and BPS Analysis by Test Kits, 2023 to 2033
Figure 186: MEA Market Y-o-Y Growth (%) Projections by Test Kits, 2023 to 2033
Figure 187: MEA Market Value (US$ Million) Analysis by Sample, 2018 to 2033
Figure 188: MEA Market Value Share (%) and BPS Analysis by Sample, 2023 to 2033
Figure 189: MEA Market Y-o-Y Growth (%) Projections by Sample, 2023 to 2033
Figure 190: MEA Market Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 191: MEA Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 192: MEA Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 193: MEA Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 194: MEA Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 195: MEA Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 196: MEA Market Attractiveness by Test Kits, 2023 to 2033
Figure 197: MEA Market Attractiveness by Sample, 2023 to 2033
Figure 198: MEA Market Attractiveness by Indication, 2023 to 2033
Figure 199: MEA Market Attractiveness by End-User, 2023 to 2033
Figure 200: MEA Market Attractiveness by Country, 2023 to 2033
